海南海药
(000566)
| 流通市值：54.85亿 | | | 总市值：54.88亿 |
| 流通股本：12.97亿 | | | 总股本：12.97亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 168,179,556.43 | 831,182,097.08 | 639,683,832.92 | 450,274,958.78 |
| 营业收入 | 168,179,556.43 | 831,182,097.08 | 639,683,832.92 | 450,274,958.78 |
| 二、营业总成本 | 279,973,216.87 | 1,257,428,004.29 | 926,345,895.47 | 632,766,596.94 |
| 营业成本 | 126,377,494.54 | 625,018,745.68 | 475,305,790.5 | 322,850,103.04 |
| 税金及附加 | 2,397,612.04 | 22,019,623.24 | 15,121,455.89 | 10,874,909.5 |
| 销售费用 | 47,384,600.38 | 150,183,399.77 | 113,371,830.98 | 85,922,946.64 |
| 管理费用 | 60,992,191.51 | 228,839,822.56 | 170,125,032.47 | 110,802,084.31 |
| 研发费用 | 2,810,617.62 | 39,685,192.28 | 27,335,705.41 | 21,518,579.22 |
| 财务费用 | 40,010,700.78 | 191,681,220.76 | 125,086,080.22 | 80,797,974.23 |
| 其中:利息费用 | 39,543,035.08 | 191,933,702.24 | 125,342,244.07 | 81,707,214.08 |
| 其中:利息收入 | 1,076,208.04 | 1,539,700.94 | 1,006,298.75 | 1,305,979.94 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 364,239.49 | 1,423,584.33 | 167,575.24 | 721,897.39 |
| 加:投资收益 | 16,589,174.24 | -4,419,649.27 | 6,038,962.2 | -1,207,563.84 |
| 资产处置收益 | 0 | -85,182.43 | -63,995.28 | 3,256,591.08 |
| 资产减值损失(新) | 245,815.64 | -9,450,953.44 | -206,323.33 | -206,323.33 |
| 信用减值损失(新) | 3,914,072.29 | -6,272,020.34 | 1,380,394.64 | -6,109,709.85 |
| 其他收益 | 7,111,904.03 | 38,557,696.56 | 21,188,544.39 | 18,040,449.83 |
| 四、营业利润 | -83,568,454.75 | -406,492,431.8 | -258,156,904.69 | -167,996,296.88 |
| 加:营业外收入 | 3,988,951.18 | 632,666.21 | 298,810.09 | 269,446.84 |
| 减:营业外支出 | 266,965.96 | 1,806,212.63 | 1,130,864.32 | 814,292.11 |
| 五、利润总额 | -79,846,469.53 | -407,665,978.22 | -258,988,958.92 | -168,541,142.15 |
| 减:所得税费用 | 1,755,984.66 | 48,518,460.37 | 3,656,564.9 | 3,480,399.08 |
| 六、净利润 | -81,602,454.19 | -456,184,438.59 | -262,645,523.82 | -172,021,541.23 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -81,602,454.19 | -456,184,438.59 | -262,645,523.82 | -172,021,541.23 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -76,452,135.09 | -429,990,843.42 | -242,307,257.15 | -158,307,106.28 |
| 少数股东损益 | -5,150,319.1 | -26,193,595.17 | -20,338,266.67 | -13,714,434.95 |
| 扣除非经常损益后的净利润 | -101,746,282.3 | -470,241,853.58 | -272,391,155.14 | -180,590,505.99 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.06 | -0.33 | -0.19 | -0.12 |
| (二)稀释每股收益 | -0.06 | -0.33 | -0.19 | -0.12 |
| 八、其他综合收益 | -875,085.06 | -9,433,774.75 | -520,704.64 | -604,695.64 |
| 归属于母公司股东的其他综合收益 | -875,085.06 | -9,433,774.75 | -520,704.64 | -604,695.64 |
| 九、综合收益总额 | -82,477,539.25 | -465,618,213.34 | -263,166,228.46 | -172,626,236.87 |
| 归属于母公司股东的综合收益总额 | -77,327,220.15 | -439,424,618.17 | -242,827,961.79 | -158,911,801.92 |
| 归属于少数股东的综合收益总额 | -5,150,319.1 | -26,193,595.17 | -20,338,266.67 | -13,714,434.95 |
| 公告日期 | 2026-04-28 | 2026-04-11 | 2025-10-30 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |